| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone phosphatase activity | 9.16e-08 | 3 | 91 | 3 | GO:0140789 | |
| GeneOntologyMolecularFunction | histone H2AXY142 phosphatase activity | 9.16e-08 | 3 | 91 | 3 | GO:0140793 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 1.02e-06 | 40 | 91 | 5 | GO:0140662 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.81e-06 | 6 | 91 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.81e-06 | 6 | 91 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 2.07e-05 | 73 | 91 | 5 | GO:0044183 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 2.41e-05 | 126 | 91 | 6 | GO:0051082 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 2.94e-05 | 39 | 91 | 4 | GO:0097718 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 4.00e-05 | 15 | 91 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | denatured protein binding | 6.14e-05 | 3 | 91 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 2.04e-04 | 5 | 91 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | PMS2 MYH11 UBA7 CHTF18 RNF213 HSPA1A HSPA1B HSPA8 HSP90AB1 HSP90AB3P | 4.82e-04 | 614 | 91 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 5.86e-04 | 36 | 91 | 3 | GO:0140416 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 9.01e-04 | 163 | 91 | 5 | GO:0031072 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 9.11e-04 | 441 | 91 | 8 | GO:0016887 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PRUNE2 PMS2 RHOD CHTF18 RNF213 HSPA1A HSPA1B ENTPD4 HSPA8 HSP90AB1 HSP90AB3P | 1.49e-03 | 839 | 91 | 11 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PRUNE2 PMS2 RHOD CHTF18 RNF213 HSPA1A HSPA1B ENTPD4 HSPA8 HSP90AB1 HSP90AB3P | 1.50e-03 | 840 | 91 | 11 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PRUNE2 PMS2 RHOD CHTF18 RNF213 HSPA1A HSPA1B ENTPD4 HSPA8 HSP90AB1 HSP90AB3P | 1.50e-03 | 840 | 91 | 11 | GO:0016818 |
| GeneOntologyMolecularFunction | protein domain specific binding | SRSF10 CAPN7 SH3KBP1 PRKDC HSPA1A HSPA1B HSPA8 TFDP1 TFDP2 HSP90AB1 HSP90AB3P | 2.07e-03 | 875 | 91 | 11 | GO:0019904 |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 2.36e-03 | 16 | 91 | 2 | GO:0004697 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | PMS2 RHOD CHTF18 RNF213 HSPA1A HSPA1B ENTPD4 HSPA8 HSP90AB1 HSP90AB3P | 2.76e-03 | 775 | 91 | 10 | GO:0017111 |
| GeneOntologyMolecularFunction | misfolded protein binding | 3.00e-03 | 18 | 91 | 2 | GO:0051787 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.97e-03 | 229 | 91 | 5 | GO:0140993 | |
| GeneOntologyMolecularFunction | death receptor activity | 4.08e-03 | 21 | 91 | 2 | GO:0005035 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 4.43e-03 | 337 | 91 | 6 | GO:0031625 | |
| GeneOntologyMolecularFunction | cadherin binding | 4.56e-03 | 339 | 91 | 6 | GO:0045296 | |
| GeneOntologyBiologicalProcess | response to temperature stimulus | HSBP1L1 ALDH18A1 HSPA1A HSPA1B CHRFAM7A CDH8 HSPA8 HSP90AB1 HSP90AB3P | 3.48e-07 | 208 | 91 | 9 | GO:0009266 |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 8.71e-07 | 40 | 91 | 5 | GO:2001240 | |
| GeneOntologyBiologicalProcess | negative regulation of signal transduction in absence of ligand | 8.71e-07 | 40 | 91 | 5 | GO:1901099 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 1.55e-06 | 81 | 91 | 6 | GO:0034605 | |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 1.65e-06 | 6 | 91 | 3 | GO:0070370 | |
| GeneOntologyBiologicalProcess | heat acclimation | 2.87e-06 | 7 | 91 | 3 | GO:0010286 | |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway in absence of ligand | 3.99e-06 | 54 | 91 | 5 | GO:2001239 | |
| GeneOntologyBiologicalProcess | telomere maintenance | 9.56e-06 | 168 | 91 | 7 | GO:0000723 | |
| GeneOntologyBiologicalProcess | response to heat | 1.60e-05 | 121 | 91 | 6 | GO:0009408 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 1.64e-05 | 333 | 91 | 9 | GO:0051054 | |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 1.78e-05 | 12 | 91 | 3 | GO:0090084 | |
| GeneOntologyBiologicalProcess | telomere organization | 2.86e-05 | 199 | 91 | 7 | GO:0032200 | |
| GeneOntologyBiologicalProcess | extrinsic apoptotic signaling pathway in absence of ligand | 3.12e-05 | 82 | 91 | 5 | GO:0097192 | |
| GeneOntologyBiologicalProcess | signal transduction in absence of ligand | 3.51e-05 | 84 | 91 | 5 | GO:0038034 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | SMG1 PMS2 NFATC1 CHTF18 NFRKB NBN PRKDC EYA1 EYA2 EYA3 TFDP1 | 3.80e-05 | 564 | 91 | 11 | GO:0051052 |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 4.11e-05 | 143 | 91 | 6 | GO:0045739 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT7 MYH11 RHOD VPS33B SH3KBP1 AKAP13 RP1 DIAPH3 PLEK HSPA1A HSPA1B CHRFAM7A HSPA8 HSP90AB1 | 7.43e-05 | 957 | 91 | 14 | GO:0097435 |
| GeneOntologyBiologicalProcess | negative regulation of protein modification process | IVNS1ABP IBTK SLC8A1 COPS9 PRKCH PRKDC SMCR8 HSPA1A HSPA1B CHRFAM7A | 8.65e-05 | 512 | 91 | 10 | GO:0031400 |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 1.04e-04 | 21 | 91 | 3 | GO:0090083 | |
| GeneOntologyBiologicalProcess | viral life cycle | 1.30e-04 | 340 | 91 | 8 | GO:0019058 | |
| GeneOntologyBiologicalProcess | negative regulation of extrinsic apoptotic signaling pathway | 1.44e-04 | 113 | 91 | 5 | GO:2001237 | |
| GeneOntologyBiologicalProcess | chromosome organization | SMG1 SETDB1 HECW2 CHTF18 NFRKB NBN PRKDC HSPA1A HSPA1B STAG2 HSP90AB1 | 2.15e-04 | 686 | 91 | 11 | GO:0051276 |
| GeneOntologyBiologicalProcess | regulation of protein stability | 2.23e-04 | 368 | 91 | 8 | GO:0031647 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | SMG1 PMS2 NFATC1 CHTF18 NFRKB NBN PRKDC EYA1 EYA2 EYA3 HSPA1A HSPA1B TFDP1 HSP90AB1 | 2.65e-04 | 1081 | 91 | 14 | GO:0006259 |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | SLC8A1 COPS9 CACNA2D4 HSBP1L1 ALDH18A1 RP1 PRKDC EYA1 EYA3 HSPA1A HSPA1B CHRFAM7A CDH8 HSPA8 HSP90AB1 HSP90AB3P | 2.78e-04 | 1361 | 91 | 16 | GO:0009628 |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 3.05e-04 | 291 | 91 | 7 | GO:0032984 | |
| GeneOntologyBiologicalProcess | protein refolding | 3.09e-04 | 30 | 91 | 3 | GO:0042026 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 3.99e-04 | 7 | 91 | 2 | GO:0070434 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-methionine acetylation | 3.99e-04 | 7 | 91 | 2 | GO:0017196 | |
| GeneOntologyBiologicalProcess | inclusion body assembly | 4.12e-04 | 33 | 91 | 3 | GO:0070841 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 4.21e-04 | 307 | 91 | 7 | GO:0018105 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | IVNS1ABP CACNA1A NAA15 LAMP3 PRKCH PRKDC EYA1 EYA2 EYA3 HSPA1A HSPA1B HSPA8 NAA16 HSP90AB1 | 4.27e-04 | 1133 | 91 | 14 | GO:0043066 |
| GeneOntologyBiologicalProcess | chaperone-mediated protein folding | 4.34e-04 | 80 | 91 | 4 | GO:0061077 | |
| GeneOntologyBiologicalProcess | organelle assembly | MYH11 VPS33B SPEF2 RNF213 AKAP13 RP1 PRKDC DIAPH3 CSMD2 SMCR8 HSPA1A HSPA1B STAG2 NME8 | 4.46e-04 | 1138 | 91 | 14 | GO:0070925 |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 4.91e-04 | 35 | 91 | 3 | GO:0051085 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with host | 5.21e-04 | 228 | 91 | 6 | GO:0051701 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 5.28e-04 | 319 | 91 | 7 | GO:0018209 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 5.30e-04 | 8 | 91 | 2 | GO:0090063 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 5.30e-04 | 8 | 91 | 2 | GO:0070426 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | IVNS1ABP KLHL2 RNF220 COPS9 UBA7 HECW2 RNF213 NBN EYA1 HSPA1A HSPA1B HSP90AB1 | 5.46e-04 | 893 | 91 | 12 | GO:0032446 |
| GeneOntologyBiologicalProcess | DNA repair | 5.70e-04 | 648 | 91 | 10 | GO:0006281 | |
| GeneOntologyBiologicalProcess | positive regulation of erythrocyte differentiation | 5.79e-04 | 37 | 91 | 3 | GO:0045648 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | IVNS1ABP CACNA1A NAA15 LAMP3 PRKCH PRKDC EYA1 EYA2 EYA3 HSPA1A HSPA1B HSPA8 NAA16 HSP90AB1 | 5.92e-04 | 1171 | 91 | 14 | GO:0043069 |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 5.97e-04 | 234 | 91 | 6 | GO:0006282 | |
| GeneOntologyBiologicalProcess | double-strand break repair via alternative nonhomologous end joining | 6.79e-04 | 9 | 91 | 2 | GO:0097681 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 7.08e-04 | 438 | 91 | 8 | GO:1902903 | |
| GeneOntologyBiologicalProcess | protein stabilization | 7.27e-04 | 243 | 91 | 6 | GO:0050821 | |
| GeneOntologyBiologicalProcess | protein folding | 7.75e-04 | 246 | 91 | 6 | GO:0006457 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 7.84e-04 | 41 | 91 | 3 | GO:0051084 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 7.96e-04 | 558 | 91 | 9 | GO:0060537 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 8.96e-04 | 349 | 91 | 7 | GO:0014706 | |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 9.17e-04 | 169 | 91 | 5 | GO:0046718 | |
| GeneOntologyBiologicalProcess | biological process involved in symbiotic interaction | 9.27e-04 | 351 | 91 | 7 | GO:0044403 | |
| GeneOntologyBiologicalProcess | negative regulation of protein metabolic process | IVNS1ABP IBTK SLC8A1 COPS9 CST9L LAMP3 PRKCH PRKDC SMCR8 HSPA1A HSPA1B CHRFAM7A HSP90AB1 | 9.50e-04 | 1088 | 91 | 13 | GO:0051248 |
| GeneOntologyBiologicalProcess | negative regulation of protein modification by small protein conjugation or removal | 1.01e-03 | 100 | 91 | 4 | GO:1903321 | |
| GeneOntologyBiologicalProcess | DNA damage response | SMG1 PLA2R1 PMS2 UBA7 NFRKB NBN PRKDC EYA1 EYA2 EYA3 HSPA1A HSPA1B | 1.02e-03 | 959 | 91 | 12 | GO:0006974 |
| GeneOntologyBiologicalProcess | viral process | 1.03e-03 | 464 | 91 | 8 | GO:0016032 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.03e-03 | 11 | 91 | 2 | GO:0070432 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 1.10e-03 | 46 | 91 | 3 | GO:0006458 | |
| GeneOntologyBiologicalProcess | symbiont entry into host | 1.10e-03 | 176 | 91 | 5 | GO:0044409 | |
| GeneOntologyBiologicalProcess | negative regulation of post-translational protein modification | 1.16e-03 | 104 | 91 | 4 | GO:1901874 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 1.19e-03 | 475 | 91 | 8 | GO:0140694 | |
| GeneOntologyBiologicalProcess | regulation of extrinsic apoptotic signaling pathway | 1.25e-03 | 181 | 91 | 5 | GO:2001236 | |
| GeneOntologyCellularComponent | COP9 signalosome | 2.03e-05 | 38 | 89 | 4 | GO:0008180 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | IVNS1ABP PMS2 COPS9 CPSF6 CHTF18 NFRKB U2AF1L4 NBN ICE1 PRKDC SNRPB2 HSPA1A HSPA1B HSPA8 TFDP1 TFDP2 HSP90AB1 | 6.12e-05 | 1377 | 89 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | NatA complex | 1.78e-04 | 5 | 89 | 2 | GO:0031415 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 1.89e-04 | 124 | 89 | 5 | GO:1904813 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 3.33e-04 | 405 | 89 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | nuclear body | SRSF10 NAA15 NFATC1 CPSF6 U2AF1L4 NBN ICE1 EYA1 SNRPB2 HSPA1A HSPA1B NME8 | 4.36e-04 | 903 | 89 | 12 | GO:0016604 |
| GeneOntologyCellularComponent | inclusion body | 5.93e-04 | 90 | 89 | 4 | GO:0016234 | |
| GeneOntologyCellularComponent | N-terminal protein acetyltransferase complex | 7.89e-04 | 10 | 89 | 2 | GO:0031414 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1A SLC8A1 PCDHB13 PCDHB8 CSMD2 CHRFAM7A UTRN CDH8 HSPA8 | 8.41e-04 | 583 | 89 | 9 | GO:0097060 |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 1.12e-03 | 48 | 89 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 1.17e-03 | 185 | 89 | 5 | GO:0101002 | |
| GeneOntologyCellularComponent | melanosome | 1.39e-03 | 113 | 89 | 4 | GO:0042470 | |
| GeneOntologyCellularComponent | pigment granule | 1.39e-03 | 113 | 89 | 4 | GO:0048770 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.63e-03 | 118 | 89 | 4 | GO:0032432 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ALDH1A2 NFATC1 VPS33B LAMP3 FSD2 AKAP13 HSPA1A HSPA1B HSPA8 HSP90AB1 HSP90AB3P | 2.02e-03 | 934 | 89 | 11 | GO:0048471 |
| Domain | EYA_fam | 4.31e-07 | 4 | 90 | 3 | IPR028472 | |
| Domain | EYA_dom | 4.31e-07 | 4 | 90 | 3 | IPR006545 | |
| Domain | NatA_aux_su | 2.30e-05 | 2 | 90 | 2 | IPR021183 | |
| Domain | NARP1 | 2.30e-05 | 2 | 90 | 2 | PF12569 | |
| Domain | BTB-kelch_protein | 5.39e-05 | 43 | 90 | 4 | IPR017096 | |
| Domain | HSP70 | 5.79e-05 | 16 | 90 | 3 | PF00012 | |
| Domain | Transc_factor_DP_C | 6.87e-05 | 3 | 90 | 2 | IPR014889 | |
| Domain | DP | 6.87e-05 | 3 | 90 | 2 | PF08781 | |
| Domain | DP | 6.87e-05 | 3 | 90 | 2 | SM01138 | |
| Domain | Transcrpt_fac_DP | 6.87e-05 | 3 | 90 | 2 | IPR015648 | |
| Domain | HSP70_2 | 7.01e-05 | 17 | 90 | 3 | PS00329 | |
| Domain | HSP70_3 | 7.01e-05 | 17 | 90 | 3 | PS01036 | |
| Domain | HSP70_1 | 7.01e-05 | 17 | 90 | 3 | PS00297 | |
| Domain | Hsp_70_fam | 8.38e-05 | 18 | 90 | 3 | IPR013126 | |
| Domain | HATPase_C | 1.35e-04 | 21 | 90 | 3 | IPR003594 | |
| Domain | Kelch | 1.75e-04 | 58 | 90 | 4 | SM00612 | |
| Domain | BACK | 2.00e-04 | 60 | 90 | 4 | SM00875 | |
| Domain | BACK | 2.13e-04 | 61 | 90 | 4 | PF07707 | |
| Domain | BACK | 2.13e-04 | 61 | 90 | 4 | IPR011705 | |
| Domain | FATC | 2.27e-04 | 5 | 90 | 2 | PF02260 | |
| Domain | - | 2.91e-04 | 27 | 90 | 3 | 2.130.10.80 | |
| Domain | FAT | 3.40e-04 | 6 | 90 | 2 | PS51189 | |
| Domain | FATC | 3.40e-04 | 6 | 90 | 2 | PS51190 | |
| Domain | FATC_dom | 3.40e-04 | 6 | 90 | 2 | IPR003152 | |
| Domain | PIK_FAT | 3.40e-04 | 6 | 90 | 2 | IPR014009 | |
| Domain | FATC | 3.40e-04 | 6 | 90 | 2 | SM01343 | |
| Domain | Kelch_1 | 3.63e-04 | 70 | 90 | 4 | PF01344 | |
| Domain | Kelch_1 | 3.63e-04 | 70 | 90 | 4 | IPR006652 | |
| Domain | Gal_Oxidase_b-propeller | 5.81e-04 | 34 | 90 | 3 | IPR015916 | |
| Domain | BTB | 1.06e-03 | 160 | 90 | 5 | PS50097 | |
| Domain | E2F_TDP | 1.23e-03 | 11 | 90 | 2 | PF02319 | |
| Domain | E2F_TDP | 1.23e-03 | 11 | 90 | 2 | SM01372 | |
| Domain | E2F_WHTH_DNA-bd_dom | 1.23e-03 | 11 | 90 | 2 | IPR003316 | |
| Domain | - | 1.47e-03 | 12 | 90 | 2 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 1.47e-03 | 12 | 90 | 2 | IPR029047 | |
| Domain | - | 1.73e-03 | 13 | 90 | 2 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.73e-03 | 13 | 90 | 2 | IPR018181 | |
| Domain | HSP70_C | 1.73e-03 | 13 | 90 | 2 | IPR029048 | |
| Domain | SEA | 2.01e-03 | 14 | 90 | 2 | SM00200 | |
| Domain | SKP1/BTB/POZ | 2.21e-03 | 189 | 90 | 5 | IPR011333 | |
| Domain | - | 2.31e-03 | 15 | 90 | 2 | 3.30.70.960 | |
| Domain | PI3/4_kinase_CS | 2.31e-03 | 15 | 90 | 2 | IPR018936 | |
| Domain | - | 2.64e-03 | 16 | 90 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.64e-03 | 16 | 90 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 3.34e-03 | 18 | 90 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 3.34e-03 | 18 | 90 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 3.34e-03 | 18 | 90 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 3.34e-03 | 18 | 90 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.34e-03 | 18 | 90 | 2 | PS00916 | |
| Domain | HATPase_c | 3.34e-03 | 18 | 90 | 2 | SM00387 | |
| Domain | BTB | 3.71e-03 | 131 | 90 | 4 | PF00651 | |
| Domain | HATPase_c | 3.72e-03 | 19 | 90 | 2 | PF02518 | |
| Domain | Ald_DH_C | 3.72e-03 | 19 | 90 | 2 | IPR016163 | |
| Domain | Ald_DH_N | 3.72e-03 | 19 | 90 | 2 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 3.72e-03 | 19 | 90 | 2 | IPR016161 | |
| Domain | - | 3.72e-03 | 19 | 90 | 2 | 3.40.605.10 | |
| Domain | Aldedh | 3.72e-03 | 19 | 90 | 2 | PF00171 | |
| Domain | Aldehyde_DH_dom | 3.72e-03 | 19 | 90 | 2 | IPR015590 | |
| Domain | - | 3.72e-03 | 19 | 90 | 2 | 3.40.309.10 | |
| Domain | Semaphorin | 4.12e-03 | 20 | 90 | 2 | IPR027231 | |
| Domain | - | 4.12e-03 | 20 | 90 | 2 | 3.30.565.10 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 4.83e-07 | 13 | 74 | 4 | MM14952 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 5.74e-06 | 23 | 74 | 4 | MM14953 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.30e-05 | 28 | 74 | 4 | M27254 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 4.51e-05 | 38 | 74 | 4 | M27255 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.33e-04 | 94 | 74 | 5 | MM14515 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.57e-04 | 52 | 74 | 4 | MM14949 | |
| Pathway | REACTOME_DNA_REPAIR | 1.75e-04 | 301 | 74 | 8 | MM15433 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 2.24e-04 | 57 | 74 | 4 | MM15298 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.24e-04 | 57 | 74 | 4 | M27251 | |
| Pathway | REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 2.69e-04 | 5 | 74 | 2 | M26903 | |
| Pathway | WP_MAPK_SIGNALING | 3.01e-04 | 246 | 74 | 7 | M39597 | |
| Pathway | REACTOME_DNA_REPAIR | 3.39e-04 | 332 | 74 | 8 | M15434 | |
| Pathway | REACTOME_BACTERIAL_INFECTION_PATHWAYS | 5.21e-04 | 71 | 74 | 4 | M48033 | |
| Pathway | KEGG_SPLICEOSOME | 5.37e-04 | 127 | 74 | 5 | M2044 | |
| Pathway | REACTOME_HSF1_ACTIVATION | 5.62e-04 | 31 | 74 | 3 | M27252 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 7.44e-04 | 78 | 74 | 4 | M27589 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 7.84e-04 | 138 | 74 | 5 | MM15635 | |
| Pathway | REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 9.56e-04 | 9 | 74 | 2 | M26946 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 1.01e-03 | 146 | 74 | 5 | MM15292 | |
| Pubmed | Function and regulation of heat shock factor 2 during mouse embryogenesis. | 3.18e-09 | 8 | 92 | 4 | 9122205 | |
| Pubmed | Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. | 3.18e-09 | 8 | 92 | 4 | 22495301 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 23352621 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 9020840 | ||
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 1.79e-08 | 3 | 92 | 3 | 15129916 | |
| Pubmed | Eyes absent represents a class of protein tyrosine phosphatases. | 1.79e-08 | 3 | 92 | 3 | 14628052 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 28025138 | ||
| Pubmed | CKB FLNB SRSF10 NAA15 CPSF6 CHTF18 SNRPB2 HSPA1A UTRN HSPA8 HSP90AB1 HSP90AB3P | 1.96e-08 | 538 | 92 | 12 | 28524877 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | CKB SETDB1 APEH PRKDC HSPA1A HSPA1B HSPA8 HSP90AB1 HSP90AB3P | 2.81e-08 | 256 | 92 | 9 | 35777956 |
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 4.29e-08 | 73 | 92 | 6 | 32347575 | |
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 7.15e-08 | 4 | 92 | 3 | 18299791 | |
| Pubmed | Misexpression of the eyes absent family triggers the apoptotic program. | 7.15e-08 | 4 | 92 | 3 | 11700312 | |
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 7.15e-08 | 4 | 92 | 3 | 22956628 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 18379898 | ||
| Pubmed | Clathrin facilitates the morphogenesis of retrovirus particles. | 8.14e-08 | 16 | 92 | 4 | 21738476 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CKB FLNB KRT7 GANAB NAA15 CPSF6 CHTF18 U2AF1L4 ALDH18A1 AKAP13 PRKDC DIAPH3 SNRPB2 HSPA1A STAG2 HSPA8 HSP90AB1 | 1.63e-07 | 1415 | 92 | 17 | 28515276 |
| Pubmed | Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. | 1.78e-07 | 5 | 92 | 3 | 10490620 | |
| Pubmed | A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. | 1.78e-07 | 5 | 92 | 3 | 11584023 | |
| Pubmed | Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. | 1.78e-07 | 5 | 92 | 3 | 16906134 | |
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 9006082 | ||
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 17182002 | ||
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 20930503 | ||
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 9195991 | ||
| Pubmed | 2.48e-07 | 51 | 92 | 5 | 36896912 | ||
| Pubmed | 2.93e-07 | 244 | 92 | 8 | 30349055 | ||
| Pubmed | Metallothionein-3 is a component of a multiprotein complex in the mouse brain. | 3.56e-07 | 6 | 92 | 3 | 17018872 | |
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 3.56e-07 | 6 | 92 | 3 | 7988674 | |
| Pubmed | Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. | 3.56e-07 | 6 | 92 | 3 | 15963462 | |
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 9305631 | ||
| Pubmed | Identification of mouse brain proteins associated with isoform 3 of metallothionein. | 3.56e-07 | 6 | 92 | 3 | 15802640 | |
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 3.56e-07 | 6 | 92 | 3 | 25281747 | |
| Pubmed | Interaction of a Novel Chaperone PhLP2A With the Heat Shock Protein Hsp90. | 3.56e-07 | 6 | 92 | 3 | 27496612 | |
| Pubmed | Heat shock factor 2 is activated during mouse heart development. | 3.56e-07 | 6 | 92 | 3 | 11032181 | |
| Pubmed | EYA4, a novel vertebrate gene related to Drosophila eyes absent. | 3.56e-07 | 6 | 92 | 3 | 9887327 | |
| Pubmed | 3.58e-07 | 104 | 92 | 6 | 36055981 | ||
| Pubmed | 4.01e-07 | 106 | 92 | 6 | 19394292 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | IVNS1ABP KRT7 SRSF10 CPSF6 CAPN7 HSPA1A HSPA1B HSPA8 HSP90AB1 | 4.28e-07 | 353 | 92 | 9 | 27545878 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | IVNS1ABP FLNB HECW2 ALDH18A1 RNF213 AKAP13 ICE1 PRKDC CSMD2 UTRN HSPA8 HSP90AB1 | 5.71e-07 | 736 | 92 | 12 | 29676528 |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 5.96e-07 | 268 | 92 | 8 | 33024031 | |
| Pubmed | 6.22e-07 | 7 | 92 | 3 | 21487019 | ||
| Pubmed | 6.22e-07 | 7 | 92 | 3 | 32162334 | ||
| Pubmed | Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. | 6.22e-07 | 7 | 92 | 3 | 10205060 | |
| Pubmed | Messenger RNA expression of heat shock proteins (HSPs) during ocular development. | 6.22e-07 | 7 | 92 | 3 | 8974842 | |
| Pubmed | 7.97e-07 | 191 | 92 | 7 | 33762435 | ||
| Pubmed | 9.81e-07 | 197 | 92 | 7 | 31620119 | ||
| Pubmed | 9.94e-07 | 8 | 92 | 3 | 25202009 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 1.02e-06 | 288 | 92 | 8 | 31501420 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | CKB IBTK ALDH1A2 NAA15 CPSF6 NBN ICE1 PRKDC SMCR8 HSPA1A UTRN HSPA8 HSP90AB1 | 1.10e-06 | 934 | 92 | 13 | 33916271 |
| Pubmed | HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells. | 1.23e-06 | 70 | 92 | 5 | 17342744 | |
| Pubmed | The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer. | 1.49e-06 | 9 | 92 | 3 | 36749630 | |
| Pubmed | 1.49e-06 | 9 | 92 | 3 | 21763498 | ||
| Pubmed | Identification of Redox and Glucose-Dependent Txnip Protein Interactions. | 1.56e-06 | 32 | 92 | 4 | 27437069 | |
| Pubmed | Proteomic analysis reveals novel binding partners of MIP-T3 in human cells. | 2.00e-06 | 34 | 92 | 4 | 20391533 | |
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 2.12e-06 | 10 | 92 | 3 | 11932435 | |
| Pubmed | 2.12e-06 | 10 | 92 | 3 | 12832005 | ||
| Pubmed | 2.12e-06 | 10 | 92 | 3 | 15870294 | ||
| Pubmed | 2.12e-06 | 10 | 92 | 3 | 7906708 | ||
| Pubmed | 2.12e-06 | 10 | 92 | 3 | 16809764 | ||
| Pubmed | 2.12e-06 | 10 | 92 | 3 | 23921388 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | CKB FLNB MYH11 NAA15 PRKDC SNRPB2 HSPA1A HSPA1B UTRN HSPA8 HSP90AB1 HSP90AB3P | 2.46e-06 | 847 | 92 | 12 | 35235311 |
| Pubmed | 2.53e-06 | 36 | 92 | 4 | 28215707 | ||
| Pubmed | ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation. | 2.91e-06 | 11 | 92 | 3 | 27708256 | |
| Pubmed | 2.91e-06 | 11 | 92 | 3 | 24318877 | ||
| Pubmed | Hsp and chaperone distribution during endochondral bone development in mouse embryo. | 2.91e-06 | 11 | 92 | 3 | 9880236 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | FLNB SETDB1 SRSF10 NAA15 CPSF6 CHTF18 APEH ALDH18A1 RNF213 PRKDC SNRPB2 HSPA1A UTRN HSPA8 HSP90AB1 | 2.92e-06 | 1367 | 92 | 15 | 32687490 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 2.94e-06 | 332 | 92 | 8 | 32786267 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | CKB SRSF10 MYH11 CPSF6 ALDH18A1 PRKDC SNRPB2 HSPA1A HSPA1B HSPA8 HSP90AB1 | 3.01e-06 | 714 | 92 | 11 | 28302793 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 3.16e-06 | 235 | 92 | 7 | 30258100 | |
| Pubmed | 3.21e-06 | 451 | 92 | 9 | 36168627 | ||
| Pubmed | 3.30e-06 | 152 | 92 | 6 | 16009940 | ||
| Pubmed | CKB FLNB GANAB NAA15 ALDH18A1 PRKDC EYA3 SNRPB2 HSPA1A HSPA1B HSPA8 HSP90AB1 | 3.55e-06 | 878 | 92 | 12 | 37223481 | |
| Pubmed | WDFY4 is required for cross-presentation in response to viral and tumor antigens. | 3.84e-06 | 156 | 92 | 6 | 30409884 | |
| Pubmed | 3.87e-06 | 12 | 92 | 3 | 12150907 | ||
| Pubmed | HIV-1 viral protein R (Vpr) and its interactions with host cell. | 3.87e-06 | 12 | 92 | 3 | 19275587 | |
| Pubmed | 4.28e-06 | 159 | 92 | 6 | 34537242 | ||
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | IVNS1ABP FLNB GANAB ALDH18A1 PRKDC SNRPB2 HSPA1B HSPA8 HSP90AB1 | 4.34e-06 | 468 | 92 | 9 | 36042349 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | CKB FLNB KRT7 SEMA3C MYH11 GANAB CAPN7 APEH HSPA1A HSPA1B HSPA8 HSP90AB1 HSP90AB3P | 4.85e-06 | 1070 | 92 | 13 | 23533145 |
| Pubmed | 5.03e-06 | 13 | 92 | 3 | 30792309 | ||
| Pubmed | UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. | 5.03e-06 | 13 | 92 | 3 | 27477512 | |
| Pubmed | 5.33e-06 | 360 | 92 | 8 | 33111431 | ||
| Pubmed | 5.41e-06 | 255 | 92 | 7 | 15324660 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.55e-06 | 256 | 92 | 7 | 33397691 | |
| Pubmed | SIX1 acts synergistically with TBX18 in mediating ureteral smooth muscle formation. | 6.38e-06 | 14 | 92 | 3 | 20110314 | |
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 6.92e-06 | 2 | 92 | 2 | 12411538 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 2868009 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 6.92e-06 | 2 | 92 | 2 | 24328534 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 3786141 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 7813466 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 6.92e-06 | 2 | 92 | 2 | 26923070 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16482515 | ||
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 6.92e-06 | 2 | 92 | 2 | 11864979 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15719414 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 26976620 | ||
| Pubmed | Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. | 6.92e-06 | 2 | 92 | 2 | 21187371 | |
| Pubmed | Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. | 6.92e-06 | 2 | 92 | 2 | 20430459 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 20235222 | ||
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 6.92e-06 | 2 | 92 | 2 | 20876613 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 20223214 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 6.92e-06 | 2 | 92 | 2 | 23704948 | |
| Interaction | CCDC117 interactions | 1.03e-07 | 26 | 91 | 5 | int:CCDC117 | |
| Interaction | BGLT3 interactions | 1.12e-06 | 75 | 91 | 6 | int:BGLT3 | |
| Interaction | ISG15 interactions | FLNB IBTK UBA7 GANAB CAPN7 RNF213 PRKDC HSPA1A HSPA1B HSPA8 HSP90AB1 KLHL26 | 2.24e-06 | 494 | 91 | 12 | int:ISG15 |
| Interaction | FYN interactions | IVNS1ABP PRUNE2 PMS2 SRSF10 CAPN7 SH3KBP1 PRKCH HSPA1A HSPA8 HSP90AB1 HSP90AB3P | 3.84e-06 | 431 | 91 | 11 | int:FYN |
| Interaction | RAD21 interactions | FLNB NAA15 HECW2 CHTF18 CST9L PRKDC HSPA1A STAG2 HSPA8 HSP90AB1 | 9.15e-06 | 384 | 91 | 10 | int:RAD21 |
| Interaction | PRKCE interactions | 1.34e-05 | 173 | 91 | 7 | int:PRKCE | |
| Interaction | HYPK interactions | 2.19e-05 | 125 | 91 | 6 | int:HYPK | |
| Interaction | LRRC28 interactions | 2.47e-05 | 13 | 91 | 3 | int:LRRC28 | |
| Interaction | PIAS1 interactions | 3.11e-05 | 353 | 91 | 9 | int:PIAS1 | |
| Interaction | RBX1 interactions | CKB FLNB IBTK COPS9 SRSF10 MYH11 GANAB PRKDC HSPA1A HSPA8 HSP90AB1 | 4.24e-05 | 558 | 91 | 11 | int:RBX1 |
| Interaction | FGD5 interactions | 4.25e-05 | 207 | 91 | 7 | int:FGD5 | |
| Interaction | TCERG1 interactions | 4.25e-05 | 207 | 91 | 7 | int:TCERG1 | |
| Interaction | HSP90AA1 interactions | STK32A SMG1 SETDB1 SRSF10 CHTF18 STK32B NFRKB NBN PRKCH PRKDC STK32C HSPA1A HSPA1B HSPA8 HSP90AB1 KLHL26 HSP90AB3P | 4.41e-05 | 1263 | 91 | 17 | int:HSP90AA1 |
| Interaction | PTPN12 interactions | 5.04e-05 | 145 | 91 | 6 | int:PTPN12 | |
| Interaction | MYLK4 interactions | 5.46e-05 | 90 | 91 | 5 | int:MYLK4 | |
| Interaction | TSSK6 interactions | 5.98e-05 | 47 | 91 | 4 | int:TSSK6 | |
| Interaction | CHMP4C interactions | FLNB SRSF10 MYH11 GANAB CPSF6 SH3KBP1 ALDH18A1 HS3ST5 RNF213 PRKDC HSP90AB1 HSP90AB3P | 6.01e-05 | 687 | 91 | 12 | int:CHMP4C |
| Interaction | ACIN1 interactions | 6.55e-05 | 301 | 91 | 8 | int:ACIN1 | |
| Interaction | SPEF2 interactions | 6.92e-05 | 18 | 91 | 3 | int:SPEF2 | |
| Interaction | SIX1 interactions | 7.06e-05 | 49 | 91 | 4 | int:SIX1 | |
| Interaction | KCTD9 interactions | 7.20e-05 | 225 | 91 | 7 | int:KCTD9 | |
| Interaction | TRAF3IP1 interactions | 7.43e-05 | 96 | 91 | 5 | int:TRAF3IP1 | |
| Interaction | ANKRD55 interactions | 7.82e-05 | 228 | 91 | 7 | int:ANKRD55 | |
| Interaction | RPS6KA4 interactions | 9.02e-05 | 100 | 91 | 5 | int:RPS6KA4 | |
| Interaction | MYLK2 interactions | 9.46e-05 | 101 | 91 | 5 | int:MYLK2 | |
| Interaction | FBXL4 interactions | 1.19e-04 | 106 | 91 | 5 | int:FBXL4 | |
| Interaction | PHLPP1 interactions | 1.32e-04 | 333 | 91 | 8 | int:PHLPP1 | |
| Interaction | KCNA3 interactions | CKB FLNB GANAB SPEF2 ALDH18A1 RNF213 RP1 PRKDC DIAPH3 SMCR8 HSPA1B HSPA8 HSP90AB1 | 1.42e-04 | 871 | 91 | 13 | int:KCNA3 |
| Interaction | TUBGCP2 interactions | 1.47e-04 | 176 | 91 | 6 | int:TUBGCP2 | |
| Interaction | MAP1B interactions | CKB CACNA1A SETDB1 APEH PRKDC HSPA1A HSPA1B HSPA8 HSP90AB1 HSP90AB3P | 1.59e-04 | 539 | 91 | 10 | int:MAP1B |
| Interaction | UBE3A interactions | 1.70e-04 | 441 | 91 | 9 | int:UBE3A | |
| Interaction | C3orf18 interactions | 1.74e-04 | 115 | 91 | 5 | int:C3orf18 | |
| Interaction | SRRM1 interactions | 1.78e-04 | 348 | 91 | 8 | int:SRRM1 | |
| Interaction | HSPH1 interactions | 1.91e-04 | 448 | 91 | 9 | int:HSPH1 | |
| Interaction | OBSL1 interactions | CKB PRUNE2 KLHL2 FLNB SRSF10 GANAB NFATC1 CPSF6 PRKDC SNRPB2 UTRN STAG2 HSP90AB1 | 2.00e-04 | 902 | 91 | 13 | int:OBSL1 |
| Interaction | CDK2 interactions | CKB FLNB GANAB ALDH18A1 NBN PRKCH PRKDC HSPA1A HSPA8 TFDP1 TFDP2 HSP90AB1 | 2.05e-04 | 783 | 91 | 12 | int:CDK2 |
| Interaction | AGRN interactions | 2.08e-04 | 267 | 91 | 7 | int:AGRN | |
| Interaction | METTL14 interactions | CKB KRT7 SRSF10 GANAB CPSF6 PRKDC SNRPB2 HSPA1A HSPA8 HSP90AB1 | 2.10e-04 | 558 | 91 | 10 | int:METTL14 |
| Interaction | TOLLIP interactions | 2.16e-04 | 358 | 91 | 8 | int:TOLLIP | |
| Interaction | PRKCG interactions | 2.21e-04 | 121 | 91 | 5 | int:PRKCG | |
| Interaction | MSH6 interactions | 2.28e-04 | 271 | 91 | 7 | int:MSH6 | |
| Interaction | SRSF10 interactions | 2.28e-04 | 271 | 91 | 7 | int:SRSF10 | |
| Interaction | ROCK1 interactions | 2.36e-04 | 192 | 91 | 6 | int:ROCK1 | |
| Interaction | HCK interactions | 2.42e-04 | 193 | 91 | 6 | int:HCK | |
| Interaction | NME1 interactions | 2.42e-04 | 193 | 91 | 6 | int:NME1 | |
| Interaction | GPRC5A interactions | 2.54e-04 | 68 | 91 | 4 | int:GPRC5A | |
| Interaction | ST13 interactions | 2.56e-04 | 195 | 91 | 6 | int:ST13 | |
| Interaction | AXL interactions | 2.65e-04 | 369 | 91 | 8 | int:AXL | |
| Interaction | MAP2K2 interactions | 2.66e-04 | 278 | 91 | 7 | int:MAP2K2 | |
| Interaction | ATP1A1 interactions | FLNB SLC8A1 NAA15 RHOD LAMP3 RNF213 PRKDC STK32C HSPA1A HSPA8 | 2.67e-04 | 575 | 91 | 10 | int:ATP1A1 |
| Interaction | CRK interactions | 2.70e-04 | 370 | 91 | 8 | int:CRK | |
| Interaction | PCDH7 interactions | 2.72e-04 | 279 | 91 | 7 | int:PCDH7 | |
| Interaction | YES1 interactions | 2.96e-04 | 375 | 91 | 8 | int:YES1 | |
| Interaction | SIX2 interactions | 2.99e-04 | 29 | 91 | 3 | int:SIX2 | |
| Interaction | SIX5 interactions | 2.99e-04 | 29 | 91 | 3 | int:SIX5 | |
| Interaction | FBXL15 interactions | 2.99e-04 | 29 | 91 | 3 | int:FBXL15 | |
| Interaction | RUFY1 interactions | RHOD ALDH18A1 RNF213 PRKDC HSPA1A HSPA1B HSPA8 HSP90AB1 HSP90AB3P | 2.99e-04 | 476 | 91 | 9 | int:RUFY1 |
| Interaction | ANK3 interactions | 3.01e-04 | 201 | 91 | 6 | int:ANK3 | |
| Interaction | POU5F1 interactions | 3.02e-04 | 584 | 91 | 10 | int:POU5F1 | |
| Interaction | RNF123 interactions | IVNS1ABP FLNB HECW2 ALDH18A1 RNF213 AKAP13 ICE1 PRKDC CSMD2 UTRN HSPA8 HSP90AB1 | 3.27e-04 | 824 | 91 | 12 | int:RNF123 |
| Interaction | HLA-DRB5 interactions | 3.31e-04 | 30 | 91 | 3 | int:HLA-DRB5 | |
| Interaction | STK35 interactions | 3.31e-04 | 30 | 91 | 3 | int:STK35 | |
| Interaction | SUMO2 interactions | CKB FLNB SETDB1 RNF213 NBN PRKDC HSPA1A STAG2 HSPA8 HSP90AB1 | 3.32e-04 | 591 | 91 | 10 | int:SUMO2 |
| Interaction | LRRC31 interactions | 3.35e-04 | 205 | 91 | 6 | int:LRRC31 | |
| Interaction | ARHGAP24 interactions | 3.49e-04 | 486 | 91 | 9 | int:ARHGAP24 | |
| Interaction | CWC15 interactions | 3.55e-04 | 134 | 91 | 5 | int:CWC15 | |
| Interaction | ARFIP1 interactions | 3.55e-04 | 134 | 91 | 5 | int:ARFIP1 | |
| Interaction | ANKK1 interactions | 3.65e-04 | 31 | 91 | 3 | int:ANKK1 | |
| Interaction | MAU2 interactions | 3.80e-04 | 136 | 91 | 5 | int:MAU2 | |
| Interaction | GRPEL1 interactions | 3.81e-04 | 210 | 91 | 6 | int:GRPEL1 | |
| Interaction | UBE2L3 interactions | 3.90e-04 | 211 | 91 | 6 | int:UBE2L3 | |
| Interaction | CCDC28A interactions | 4.02e-04 | 32 | 91 | 3 | int:CCDC28A | |
| Interaction | MCIDAS interactions | 4.17e-04 | 7 | 91 | 2 | int:MCIDAS | |
| Interaction | RP1L1 interactions | 4.17e-04 | 7 | 91 | 2 | int:RP1L1 | |
| Interaction | RNF207 interactions | 4.17e-04 | 7 | 91 | 2 | int:RNF207 | |
| Interaction | CHMP4B interactions | FLNB SRSF10 MYH11 CAPN7 SH3KBP1 ALDH18A1 PRKDC HSPA1A HSPA8 HSP90AB1 HSP90AB3P | 4.28e-04 | 727 | 91 | 11 | int:CHMP4B |
| Interaction | SWAP70 interactions | 4.30e-04 | 78 | 91 | 4 | int:SWAP70 | |
| Interaction | CDCA5 interactions | 4.34e-04 | 140 | 91 | 5 | int:CDCA5 | |
| Interaction | NAA40 interactions | CKB IBTK ALDH1A2 NAA15 CPSF6 NBN ICE1 PRKDC SMCR8 HSPA1A UTRN HSPA8 HSP90AB1 | 4.36e-04 | 978 | 91 | 13 | int:NAA40 |
| Interaction | ZRANB3 interactions | 4.41e-04 | 33 | 91 | 3 | int:ZRANB3 | |
| Interaction | PNPLA5 interactions | 4.41e-04 | 33 | 91 | 3 | int:PNPLA5 | |
| Interaction | GNB2 interactions | CACNA1A CHTF18 ALDH18A1 RNF213 EYA2 HSPA1A HSPA1B HSPA8 HSP90AB1 | 4.41e-04 | 502 | 91 | 9 | int:GNB2 |
| Interaction | WDFY4 interactions | 4.48e-04 | 141 | 91 | 5 | int:WDFY4 | |
| Interaction | ATOH1 interactions | 4.73e-04 | 80 | 91 | 4 | int:ATOH1 | |
| Interaction | SYNE2 interactions | 4.75e-04 | 219 | 91 | 6 | int:SYNE2 | |
| Interaction | RNF31 interactions | 4.77e-04 | 403 | 91 | 8 | int:RNF31 | |
| Interaction | MAPK7 interactions | 4.78e-04 | 143 | 91 | 5 | int:MAPK7 | |
| Interaction | CSK interactions | IVNS1ABP AFMID IBTK SLC8A1 VPS33B HECW2 FSD2 XYLB HSPA1A HSPA8 NME8 HSP90AB1 | 4.85e-04 | 861 | 91 | 12 | int:CSK |
| Interaction | PFN1 interactions | 4.87e-04 | 509 | 91 | 9 | int:PFN1 | |
| Interaction | SMC3 interactions | 5.18e-04 | 408 | 91 | 8 | int:SMC3 | |
| Interaction | PRKCA interactions | 5.18e-04 | 408 | 91 | 8 | int:PRKCA | |
| Interaction | GSK3B interactions | IBTK RNF220 GANAB NFATC1 HECW2 APEH PRKDC EYA1 HSPA1A UTRN HSPA8 HSP90AB1 | 5.21e-04 | 868 | 91 | 12 | int:GSK3B |
| Interaction | USP50 interactions | 5.25e-04 | 35 | 91 | 3 | int:USP50 | |
| Interaction | TRIM37 interactions | AFMID FLNB KRT7 CPSF6 NFRKB PRKDC DIAPH3 HSPA1B HSPA8 HSP90AB1 | 5.48e-04 | 630 | 91 | 10 | int:TRIM37 |
| Interaction | SPDL1 interactions | 5.62e-04 | 315 | 91 | 7 | int:SPDL1 | |
| Interaction | STIP1 interactions | FLNB SRSF10 NAA15 PRKDC STK32C EYA3 HSPA1A HSPA1B STAG2 HSPA8 TFDP2 HSP90AB1 HSP90AB3P | 5.69e-04 | 1006 | 91 | 13 | int:STIP1 |
| Interaction | FAM83F interactions | 5.71e-04 | 36 | 91 | 3 | int:FAM83F | |
| Interaction | METTL21A interactions | 5.71e-04 | 36 | 91 | 3 | int:METTL21A | |
| Interaction | KBTBD4 interactions | 5.73e-04 | 316 | 91 | 7 | int:KBTBD4 | |
| Interaction | PPP6C interactions | 5.88e-04 | 228 | 91 | 6 | int:PPP6C | |
| GeneFamily | EYA transcriptional coactivator and phosphatases | 2.03e-07 | 4 | 68 | 3 | 1044 | |
| GeneFamily | Kelch like|BTB domain containing | 1.84e-05 | 42 | 68 | 4 | 617 | |
| GeneFamily | Heat shock 70kDa proteins | 3.33e-05 | 17 | 68 | 3 | 583 | |
| GeneFamily | Transcription factor Dp family | 4.17e-05 | 3 | 68 | 2 | 987 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 8.98e-04 | 12 | 68 | 2 | 660 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.63e-03 | 134 | 68 | 4 | 861 | |
| GeneFamily | Aldehyde dehydrogenases | 2.29e-03 | 19 | 68 | 2 | 398 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 2.53e-03 | 20 | 68 | 2 | 736 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.27e-03 | 26 | 68 | 2 | 253 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN | 3.82e-06 | 260 | 92 | 8 | M41075 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 4.93e-06 | 10 | 92 | 3 | MM1243 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.82e-05 | 155 | 92 | 6 | M39246 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.90e-07 | 199 | 92 | 7 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 1.83e-06 | 177 | 92 | 6 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 1.90e-06 | 178 | 92 | 6 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.23e-06 | 183 | 92 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.52e-06 | 187 | 92 | 6 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 188 | 92 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.76e-06 | 190 | 92 | 6 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-06 | 190 | 92 | 6 | 498bbe063bc75d323cb186a82cce122b511d2cff | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.40e-06 | 197 | 92 | 6 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.40e-06 | 197 | 92 | 6 | 4797f414330316e2ac2cf7cd2570d991877d7a38 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.71e-06 | 200 | 92 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 2.11e-05 | 161 | 92 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.37e-05 | 165 | 92 | 5 | 3c8baed838eccb6e720bacb7458f087647dc1222 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.37e-05 | 165 | 92 | 5 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.51e-05 | 167 | 92 | 5 | e488d9c7cf4355959e3833de3bd496c13fc11b1b | |
| ToppCell | Control-CD4+_T_activated|World / Disease group and Cell class | 2.98e-05 | 173 | 92 | 5 | 12f8e4276b290bb388a56de4c8d8dd60415b2f63 | |
| ToppCell | Control-CD4+_T_activated|Control / Disease group and Cell class | 3.06e-05 | 174 | 92 | 5 | 2b683e81b315ad22555314433aed5681feb48da8 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-05 | 174 | 92 | 5 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 176 | 92 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 177 | 92 | 5 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.60e-05 | 180 | 92 | 5 | c4068fe47408cfd899131a85fa4b7e5908926f94 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 180 | 92 | 5 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.69e-05 | 181 | 92 | 5 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.79e-05 | 182 | 92 | 5 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-05 | 182 | 92 | 5 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-05 | 182 | 92 | 5 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.89e-05 | 183 | 92 | 5 | f3728b1a51951c7349f77a3e4d2671ca3a8d2a44 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.89e-05 | 183 | 92 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.99e-05 | 184 | 92 | 5 | 087666ba949b129c53d7ace40f9e543e3875a7de | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.99e-05 | 184 | 92 | 5 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | 8939b6d795992775df0ff58ed1ec9d421a00bcc4 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.10e-05 | 185 | 92 | 5 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.31e-05 | 187 | 92 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.42e-05 | 188 | 92 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-05 | 188 | 92 | 5 | c74771584b3ba9561a99a54bf55a9203ddf8eff8 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.42e-05 | 188 | 92 | 5 | 9155b9a92496e75646778c025b02947e9e9ec73a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.42e-05 | 188 | 92 | 5 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.54e-05 | 189 | 92 | 5 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 4.54e-05 | 189 | 92 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 190 | 92 | 5 | 223587b5df037794a2cee234babf87d12bf48ac8 | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.65e-05 | 190 | 92 | 5 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | COVID-19-kidney-Stressed_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.77e-05 | 191 | 92 | 5 | d35aa842b813ea0eff7362abc894cca4e86b2fb2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-05 | 192 | 92 | 5 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.01e-05 | 193 | 92 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-05 | 193 | 92 | 5 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | ILEUM-inflamed-(2)_B_cell-(2)_Memory_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.01e-05 | 193 | 92 | 5 | a2ca508b1a6184579083f59419f4701c28d379ab | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-05 | 193 | 92 | 5 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-05 | 193 | 92 | 5 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 5.14e-05 | 194 | 92 | 5 | 335c6c2f3f319d4f19eace62f8826a0f40c130f6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.26e-05 | 195 | 92 | 5 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.26e-05 | 195 | 92 | 5 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.39e-05 | 196 | 92 | 5 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.39e-05 | 196 | 92 | 5 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.39e-05 | 196 | 92 | 5 | 629236f95c838a473b5964a49b7c1b7ad863ea12 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.52e-05 | 197 | 92 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | myeloid-Monocyte-CD16+_Monocyte|myeloid / Lineage, cell class and subclass | 5.52e-05 | 197 | 92 | 5 | 7ed5dc82ead20406586252ef07164afad8a49994 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.52e-05 | 197 | 92 | 5 | 0b2ad6a933ff1a325649cc8f139380fd158a1d42 | |
| ToppCell | COVID-19_Severe-NK_activated|World / disease group, cell group and cell class | 5.52e-05 | 197 | 92 | 5 | a60db36d1a192998e3ded63e0c7c08d41689f95f | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.66e-05 | 198 | 92 | 5 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | myeloid-Monocyte-CD16+_Monocyte|Monocyte / Lineage, cell class and subclass | 5.66e-05 | 198 | 92 | 5 | a41fa60098e59add84a1687a303c710ab1baa137 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.66e-05 | 198 | 92 | 5 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.66e-05 | 198 | 92 | 5 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 5.66e-05 | 198 | 92 | 5 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-05 | 198 | 92 | 5 | 294a48ef6c0b89c7be948452cea79d23d3901e75 | |
| ToppCell | mLN-B_cell-B_cell_memory|B_cell / Region, Cell class and subclass | 5.66e-05 | 198 | 92 | 5 | e2c63ca9f82f8524447e398b11a676b22d2f58ce | |
| ToppCell | remission-NK|World / disease stage, cell group and cell class | 5.66e-05 | 198 | 92 | 5 | 383ed78164ad37826100d3de6c3cc14f62e01813 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-05 | 198 | 92 | 5 | ec115c4a5dbc54206c72140aa0c8d6a7c29c5563 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.66e-05 | 198 | 92 | 5 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.66e-05 | 198 | 92 | 5 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.66e-05 | 198 | 92 | 5 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.66e-05 | 198 | 92 | 5 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.66e-05 | 198 | 92 | 5 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-05 | 198 | 92 | 5 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.79e-05 | 199 | 92 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class | 5.79e-05 | 199 | 92 | 5 | edf5f80b4c299e6bf462675f2cd3329d86c923d8 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.79e-05 | 199 | 92 | 5 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.79e-05 | 199 | 92 | 5 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.79e-05 | 199 | 92 | 5 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | remission-NK|remission / disease stage, cell group and cell class | 5.79e-05 | 199 | 92 | 5 | 31ed2a314e8f70980ea0686242446d66929288e9 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.79e-05 | 199 | 92 | 5 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.79e-05 | 199 | 92 | 5 | 4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.79e-05 | 199 | 92 | 5 | eb05ccae5187e4701bbbe6d714a6d2808fbcf306 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.79e-05 | 199 | 92 | 5 | 10c8729b779073c3bf808e85958d59147f0be5c5 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-05 | 199 | 92 | 5 | 54b64f01e7a73a88bd92b6d4e73cccde60396b2d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.79e-05 | 199 | 92 | 5 | 867fd292f3879982422e840e087bfdb3b21a8715 | |
| ToppCell | Control-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class | 5.79e-05 | 199 | 92 | 5 | 94b2693a8378b9b2c58c6aebb2c6658d75b2e3de | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 5.79e-05 | 199 | 92 | 5 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | H1299-uninfected|H1299 / Cell line, Condition and Strain | 5.79e-05 | 199 | 92 | 5 | 4594eb3e6d29285155df8dfd322ccf532d7e94b8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | remission-CD8+_Tem|World / disease stage, cell group and cell class | 5.93e-05 | 200 | 92 | 5 | 0ebf0dda91fc7adb9ea69734ad9dcc65d0082c6d | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.93e-05 | 200 | 92 | 5 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.93e-05 | 200 | 92 | 5 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | proximal-mesenchymal-Fibromyocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.93e-05 | 200 | 92 | 5 | 37d9f46f727a31e8e94e348e4ddd71a2125ba01a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.93e-05 | 200 | 92 | 5 | 030efc36bbb848da31b0db3f74d46aac9c79cc9b | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.93e-05 | 200 | 92 | 5 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | proximal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.93e-05 | 200 | 92 | 5 | ed6fbe61a04d29b105054f7058abe7469314b304 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class | 5.93e-05 | 200 | 92 | 5 | c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.93e-05 | 200 | 92 | 5 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.93e-05 | 200 | 92 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.27e-04 | 50 | 56 | 4 | GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.27e-04 | 50 | 56 | 4 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 2.64e-07 | 5 | 89 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | eye disease (implicated_via_orthology) | 5.27e-07 | 6 | 89 | 3 | DOID:5614 (implicated_via_orthology) | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 9.20e-07 | 7 | 89 | 3 | DOID:14702 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | IVNS1ABP SETDB1 ALDH1A2 STAB2 NBN AKAP13 PRKDC HSPA1A HSP90AB1 | 1.02e-04 | 616 | 89 | 9 | C0033578 |
| Disease | Malignant neoplasm of prostate | IVNS1ABP SETDB1 ALDH1A2 STAB2 NBN AKAP13 PRKDC HSPA1A HSP90AB1 | 1.02e-04 | 616 | 89 | 9 | C0376358 |
| Disease | posterior thigh muscle fat infiltration measurement | 1.62e-04 | 35 | 89 | 3 | EFO_0020934 | |
| Disease | Major depression, single episode | 3.19e-04 | 9 | 89 | 2 | C0024517 | |
| Disease | aspartate aminotransferase measurement | CKB FLNB SETDB1 ALDH1A2 HMCN2 HSBP1L1 RNF213 AKAP13 EYA1 EYA2 | 3.96e-04 | 904 | 89 | 10 | EFO_0004736 |
| Disease | response to carboplatin, response to antineoplastic agent | 3.98e-04 | 10 | 89 | 2 | GO_0097327, GO_0097328 | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 5.82e-04 | 12 | 89 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | Metastatic melanoma | 5.89e-04 | 54 | 89 | 3 | C0278883 | |
| Disease | salicylurate measurement | 6.87e-04 | 13 | 89 | 2 | EFO_0010532 | |
| Disease | obsolete_red blood cell distribution width | SEMA3C SRSF10 VPS33B HECW2 NFRKB APEH AKAP13 RP1 PLEK SMCR8 HSPA8 HSP90AB1 | 7.18e-04 | 1347 | 89 | 12 | EFO_0005192 |
| Disease | Rhabdomyosarcoma | 9.21e-04 | 15 | 89 | 2 | C0035412 | |
| Disease | melanoma | 9.42e-04 | 248 | 89 | 5 | C0025202 | |
| Disease | BMI-adjusted waist-hip ratio, physical activity measurement | 1.20e-03 | 69 | 89 | 3 | EFO_0007788, EFO_0008002 | |
| Disease | disease free survival | 1.33e-03 | 18 | 89 | 2 | EFO_0000409 | |
| Disease | temporal horn of lateral ventricle volume measurement | 1.36e-03 | 72 | 89 | 3 | EFO_0010333 | |
| Disease | abnormal paneth cell measurement | 1.49e-03 | 19 | 89 | 2 | EFO_0007963 | |
| Disease | citrulline measurement | 1.65e-03 | 20 | 89 | 2 | EFO_0009777 | |
| Disease | longevity | 1.71e-03 | 284 | 89 | 5 | EFO_0004300 | |
| Disease | Glioma | 2.34e-03 | 87 | 89 | 3 | C0017638 | |
| Disease | Carcinoma, Pancreatic Ductal | 2.38e-03 | 24 | 89 | 2 | C0887833 | |
| Disease | complement C4b measurement | 2.58e-03 | 25 | 89 | 2 | EFO_0008092 | |
| Disease | Ischemic stroke, coronary artery disease | 2.74e-03 | 92 | 89 | 3 | EFO_0001645, HP_0002140 | |
| Disease | macular degeneration (is_marker_for) | 2.79e-03 | 26 | 89 | 2 | DOID:4448 (is_marker_for) | |
| Disease | multisite chronic pain | 3.01e-03 | 95 | 89 | 3 | EFO_0010100 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DEDEFQITEHNNFRT | 1726 | O00555 | |
| VEDDFHNQFAAELEV | 11 | Q8WVB6 | |
| IHLAFNDIDVEPQFD | 616 | Q7Z408 | |
| EKAVHADFFNDFEDL | 36 | Q8WXC6 | |
| FADADLDYAVEQAHQ | 296 | O94788 | |
| EQESQIFHDIIVEDF | 131 | Q9Y5Z6 | |
| VFVVAEEDFHFVQDE | 81 | Q12802 | |
| HFSFQEEEQIDFQEG | 221 | P46597 | |
| FEKEFTDHQETQAEL | 516 | Q9NSV4 | |
| EDEHAAAHAEEAFFN | 91 | Q9Y235 | |
| EEVSEALHDVDFQQL | 211 | Q9H0I3 | |
| FFNDLEECDQVHVED | 356 | Q99504 | |
| FEELHDVDHFEIVEN | 271 | Q63HM1 | |
| LHIDSDEEDHEFQQD | 461 | Q9P2P5 | |
| EFFQAELQVIDINDH | 116 | Q9Y5F0 | |
| KEAFEVFDHESNNTV | 156 | Q5VUJ9 | |
| HHGEEEVETFAFQAE | 6 | P08238 | |
| DELHVQEEFEAFVAA | 126 | A6NCF5 | |
| EHFPEFENDVEFTER | 381 | P17735 | |
| EEEFERIHQAQAAAA | 656 | Q6P4R8 | |
| AEVFGSDDDHIQFVQ | 241 | Q9Y6Y0 | |
| EAEQQQLIDDHFLFD | 181 | P12277 | |
| EDEINHRTAAENEFV | 181 | P08729 | |
| VNFHEDDNQKSAFEV | 671 | Q9P2D0 | |
| HHGEEEVETFAFQAE | 6 | Q58FF7 | |
| DADLQVQDFEEHYVQ | 4521 | Q8NDA2 | |
| LHFQEFDLENINDVV | 566 | P98073 | |
| DEEDVDFDIIHNAND | 791 | O75369 | |
| VVKASQEIHFFDNDE | 116 | Q8IZT8 | |
| EDFDNRLVNHFVEEF | 231 | P0DMV9 | |
| VERHFFEITDDQFDF | 511 | Q6N069 | |
| DTHLFFNDLEECDQV | 371 | Q99502 | |
| NNNQFFHDVEVEDVL | 131 | O95644 | |
| TDVQLQAFDFEDDHF | 356 | Q9UQV4 | |
| DIADERFDATFHTNV | 26 | Q494W8 | |
| IERHFIEITDDQFDF | 511 | Q9BXJ9 | |
| TEDENTAEFFLQHVD | 701 | P54886 | |
| HDNVHAVFQEAAEVA | 176 | O00212 | |
| DHDHFFDEDLQAAID | 321 | Q9Y2F5 | |
| AFTFRHFLQIAEEED | 186 | Q53HC5 | |
| DHIDIYADVGEEFNQ | 6 | Q16630 | |
| HFLVTQAFDEDEKEN | 91 | Q9Y6W3 | |
| EAAEEADLNHEFNES | 146 | Q7Z3S7 | |
| EDFDNRLVNHFVEEF | 231 | P0DMV8 | |
| VDEFINVRLHEADND | 721 | P55286 | |
| FEDDIDNCHFQESTE | 101 | Q9H4G1 | |
| RHDIAFVEFENDGQA | 186 | P08579 | |
| HENDNAFLANEEKAI | 4021 | Q9NZJ4 | |
| EDFDNRMVNHFIAEF | 231 | P11142 | |
| EFFQAELQVIDINDH | 116 | Q9UN66 | |
| ESFEELENHDTDIFN | 1466 | P56715 | |
| FFNDLEDCDQIHVDD | 321 | O00167 | |
| DVEEVKDQFATHEAF | 341 | P46939 | |
| DTLVQEAIQAFHDNE | 591 | Q9C093 | |
| DSLVEHDEEFVQRQD | 561 | Q8WUY3 | |
| HFDELEDVFLLETDN | 301 | Q99985 | |
| LITEENEEEHNFFLA | 251 | O60934 | |
| QQDHFFQAAFLEERD | 76 | P08567 | |
| DAAENLFQELQEHFQ | 16 | C9JCN9 | |
| EADVLEVDQGFDDHN | 406 | Q14697 | |
| NFVLGRFEHIEDDDE | 231 | Q9Y227 | |
| ENFANHLEEVFITVE | 231 | A1L4K1 | |
| NFFDDDNHRQVLEEI | 3006 | Q96Q15 | |
| VEFDYQAQHDDELTI | 6 | Q96B97 | |
| DAVDIEHENNNRFEE | 341 | Q5VTB9 | |
| HQHLEEEFISEVENA | 266 | Q9BZV3 | |
| VFDENEDVNFDHFEI | 11 | Q8WU08 | |
| LASFAHIEEENFVNE | 706 | Q13018 | |
| NFDNTFEIHDDIEVL | 301 | Q14188 | |
| DEYFANLDHIESVEN | 851 | Q15047 | |
| HITNFLFEDFVEVDD | 366 | Q8TEV9 | |
| VFDDKEDVNFDHFQI | 81 | Q86UX6 | |
| AVEQVLQEEHFDASH | 566 | P13798 | |
| DFHEQIADLQAQIAE | 1066 | P35749 | |
| DQHQLDTILFFDEAN | 2476 | Q63HN8 | |
| DFCFQEIEKDIHNFE | 31 | Q8N8H1 | |
| NFDNTFEIHDDIEVL | 286 | Q14186 | |
| LNEDEILHFAVAEAD | 56 | Q8N427 | |
| VQFEDVRDAEDALHN | 56 | O75494 | |
| DDDSNFHVDFVVAAA | 811 | P41226 | |
| LSFILDHVFIEQDDD | 826 | Q8N3U4 | |
| DAELNVFYEESVHFD | 26 | O75191 | |
| AARDHVFSFDLQAEE | 76 | Q9H3T2 | |
| GFQHFESEEDINVAA | 2491 | Q8WWQ8 | |
| DVEVQEHYDSFFEEV | 71 | Q8WU68 | |
| LNEDIFIVDQHATDE | 691 | P54278 | |
| AFQHLSEAVQAAEEE | 3381 | P78527 | |
| VFDENEEVNFDHFQI | 11 | Q9NY57 | |
| SVAFEDVAVNFTHEE | 51 | P15621 | |
| AEDKVFNEIRNEHFS | 281 | Q9H267 | |
| AEQHFADVVLSEEFL | 181 | O95198 | |
| HAPFEAENEDDLFEA | 551 | P24723 | |
| DDDIFEEDENFLVHL | 481 | P32418 |